| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Caffeic Acid | Colitis | 1 | PM | 34867926 | 📋 | Caffeic Acid Supplement Alleviates Colonic Inflammation and Oxidative Stress Potentially Through Improved Gut Microbiota Community in Mice |
| Caffeic Acid | Colorectal Cancer | 2 | PM | 33425893 | 📋 | A Novel Therapeutic Approach for Colorectal Cancer Stem Cells: Blocking the PI3K/Akt Signaling Axis With Caffeic Acid |
| Caffeic Acid | Dysbiosis | 1 | PM | 33992352 | 📋 | Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice |
| Caffeic Acid | Hepatitis C | 1 | PM | 31061319 | 📋 | Inhibition Mechanisms of Hepatitis C Virus Infection by Caffeic Acid and Tannic Acid |
| Caffeic Acid | Inflammatory Bowel Disease | 1 | PM | 33567596 | 📋 | Caffeic Acid Modulates Processes Associated with Intestinal Inflammation |
| Caffeic Acid | MAFLD | 2 | PM | 35269912 | 📋 | Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates |
| Caffeic Acid | MAFLD | 1 | PM | 33992352 | 📋 | Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice |
| Caffeic Acid | Ulcerative Colitis | 1 | PM | 33932876 | 📋 | Blockade of TLRs-triggered macrophage activation by caffeic acid exerted protective effects on experimental ulcerative colitis |
